266 related articles for article (PubMed ID: 18217131)
1. Platelet functions and clinical effects in acute myelogenous leukemia.
Foss B; Bruserud O
Thromb Haemost; 2008 Jan; 99(1):27-37. PubMed ID: 18217131
[TBL] [Abstract][Full Text] [Related]
2. Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts.
Bruserud Ø; Ryningen A; Wergeland L; Glenjen NI; Gjertsen BT
Haematologica; 2004 Apr; 89(4):391-402. PubMed ID: 15075072
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute myelogenous leukemia blasts on platelet release of soluble P-selectin and platelet-derived growth factor.
Bruserud Ø; Foss B; Ulvestad E; Hervig T
Platelets; 1998; 9(6):352-8. PubMed ID: 16793718
[TBL] [Abstract][Full Text] [Related]
4. Platelet-released supernatants enhance hematopoietic stem cell proliferation in vitro.
Foss B; Bruserud O; Hervig T
Platelets; 2008 Mar; 19(2):155-9. PubMed ID: 18297552
[TBL] [Abstract][Full Text] [Related]
5. Lipoteichoic acid derived from Enterococcus faecalis modulates the functional characteristics of both normal peripheral blood leukocytes and native human acute myelogenous leukemia blasts.
Bruserud Ø; Wendelbo Ø; Paulsen K
Eur J Haematol; 2004 Nov; 73(5):340-50. PubMed ID: 15458513
[TBL] [Abstract][Full Text] [Related]
6. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.
Ryningen A; Apelseth T; Hausken T; Bruserud Ø
Platelets; 2006 Aug; 17(5):296-302. PubMed ID: 16928601
[TBL] [Abstract][Full Text] [Related]
7. Effects of cytarabine and various anthracyclins on platelet activation: characterization of in vitro effects and their possible clinical relevance in acute myelogenous leukemia.
Foss B; Ulvestad E; Hervig T; Bruserud Ø
Int J Cancer; 2002 Jan; 97(1):106-14. PubMed ID: 11774251
[TBL] [Abstract][Full Text] [Related]
8. Defective in vitro growth of primitive hematopoietic cells from pediatric patients with acute myeloid leukemia.
Dorantes-Acosta E; Chávez-González A; Santos JI; Medina-Sanson A; Mayani H
Pediatr Blood Cancer; 2008 Dec; 51(6):741-6. PubMed ID: 18680148
[TBL] [Abstract][Full Text] [Related]
9. In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8.
Ryningen A; Wergeland L; Glenjen N; Gjertsen BT; Bruserud O
Leuk Res; 2005 Feb; 29(2):185-96. PubMed ID: 15607368
[TBL] [Abstract][Full Text] [Related]
10. Autologous stem cell transplantation as post-remission therapy in adult acute myelogenous leukemia: does platelet contamination of peripheral blood mobilized stem cell grafts influence the risk of leukemia relapse?
Bruserud O; Foss B; Abrahamsen JF; Gjertsen BT; Ernst P
J Hematother Stem Cell Res; 2000 Aug; 9(4):433-43. PubMed ID: 10982241
[TBL] [Abstract][Full Text] [Related]
11. Maturation hierarchy of leukemic stem cells.
Löwenberg B; Terpstra W
Stem Cells; 1998; 16 Suppl 1():85-8; discussion 89. PubMed ID: 11012150
[TBL] [Abstract][Full Text] [Related]
12. Update on the management of pediatric acute promyelocytic leukemia.
Ribeiro R
Clin Adv Hematol Oncol; 2006 Apr; 4(4):263-5. PubMed ID: 16728936
[No Abstract] [Full Text] [Related]
13. Treatment of acute myeloid leukemia by directly targeting both leukemia stem cells and oncogenic molecule with specific scFv-immunolipoplexes as a deliverer.
Wang GP; Qi ZH; Chen FP
Med Hypotheses; 2008; 70(1):122-7. PubMed ID: 17566667
[TBL] [Abstract][Full Text] [Related]
14. The effect of steroid on myeloid leukemic cells: the potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis.
Hiçsönmez G
Leuk Res; 2006 Jan; 30(1):60-8. PubMed ID: 15979702
[TBL] [Abstract][Full Text] [Related]
15. Platelet-vessel wall interactions in atherosclerotic disease.
Langer HF; Gawaz M
Thromb Haemost; 2008 Mar; 99(3):480-6. PubMed ID: 18327395
[TBL] [Abstract][Full Text] [Related]
16. The role of platelet/endothelial cell adhesion molecule 1 (CD31) and CD38 antigens in marrow microenvironmental retention of acute myelogenous leukemia cells.
Gallay N; Anani L; Lopez A; Colombat P; Binet C; Domenech J; Weksler BB; Malavasi F; Herault O
Cancer Res; 2007 Sep; 67(18):8624-32. PubMed ID: 17875702
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells.
Mahlknecht U; Schönbein C
Haematologica; 2008 Mar; 93(3):443-6. PubMed ID: 18268283
[TBL] [Abstract][Full Text] [Related]
18. Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells.
Stellos K; Bigalke B; Langer H; Geisler T; Schad A; Kögel A; Pfaff F; Stakos D; Seizer P; Müller I; Htun P; Lindemann S; Gawaz M
Eur Heart J; 2009 Mar; 30(5):584-93. PubMed ID: 19109356
[TBL] [Abstract][Full Text] [Related]
19. New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of aml cells--the present use in experimental studies and the possible importance for future therapeutic approaches.
Bruserud O; Gjertsen BT; Foss B; Huang TS
Stem Cells; 2001; 19(1):1-11. PubMed ID: 11209086
[TBL] [Abstract][Full Text] [Related]
20. Contents of total and protein-bound carbohydrates are low in leukemic leukocytes from patients with acute myelogenous leukemia.
Smoleńska-Sym G; Zdebska E; Gołaszewska E; Woźniak J; Durzyński T; Maj S; Mokras U; Kościelak J
Acta Biochim Pol; 1998; 45(2):361-71. PubMed ID: 9821867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
